Comings; David E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Comings; David E..The latest application filed is for "methods and compositions for acid phosphatase-1 gene inhibition".

Company Profile

0.8.13

Comings; David E. - Duarte CA
Comings; David E. - Monrovia CA
Comings, David E - Duarte CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and compositions for acid phosphatase-1 gene inhibition Grant 8,034,794 - Comings , et al. October 11, 2	2011-10-11
Methods and compositions for acid phosphatase-1 gene inhibition App 20100280103 - Comings; David E. ; et al.	2010-11-04
Methods And Compositions For Acid Phosphatase-1 Gene Inhibition App 20080241928 - COMINGS; David E. ; et al.	2008-10-02
Treatment of oppositional defiant disorder and conduct disorder with 5-aminoalkyl-4,5,6,7-tetrahydro-4-oxyindolones Grant 6,897,212 - Comings , et al. May 24, 2	2005-05-24
Association between the acid phosphatase (ACP1) gene and Alzheimer's disease Grant 6,869,768 - Comings , et al. March 22, 2	2005-03-22
Acid phosphatase (acp1)gene as a susceptibility locus for hyperlipidemia App 20050055732 - Comings, David E ; et al.	2005-03-10
Treatment of oppositional defiant disorder and conduct disorder with 5-aminoalkyl-4,5,6,7-tetrahydro-4-oxyindolones App 20040116502 - Comings, David E. ; et al.	2004-06-17
Method for risk assessment for polygenic disorders App 20040115701 - Comings, David E. ; et al.	2004-06-17
Association of the muscarinic cholinergic 2 receptor (CHRM2) gene with major depression in women Grant 6,743,589 - Comings , et al. June 1, 2	2004-06-01
Use of ROC plots of genetic risk factor to predict risk of sporadic breast cancer App 20030232398 - MacMurray, James P. ; et al.	2003-12-18
Polymorphisms in the PNMT gene Grant 6,660,476 - Comings , et al. December 9, 2	2003-12-09
Association of the serotonin transport (HTT) gene with cardiovascular disease and longevity Grant 6,653,073 - Comings , et al. November 25, 2	2003-11-25
Use of molindone to treat oppositional defiant disorder and conduct disorder Grant 6,613,763 - Comings , et al. September 2, 2	2003-09-02
Multi-gene tests with ROC plots for the assessment of risk for polygenic disorders App 20030162207 - Comings, David E. ; et al.	2003-08-28
Association between the acid phosphatase (ACP1) gene and Alzheimer's disease App 20030110523 - Comings, David E. ; et al.	2003-06-12
Association of the muscarinic cholinergic 2 receptor (CHRM2) gene with major depression in women App 20030087267 - Comings, David E. ; et al.	2003-05-08
Polymorphisms associated with internalizing disorders App 20030079236 - Comings, David E. ; et al.	2003-04-24
Polymorphisms in the PNMT gene App 20020187474 - Comings, David E. ; et al.	2002-12-12
Use Of Molindone To Treat Oppositional Defiant Disorder And Conduct Disorder App 20020156078 - Comings, David E. ; et al.	2002-10-24
Method of profiling genes as risk factors for attention deficit hyperactivity disorder App 20020045171 - Comings, David E.	2002-04-18
Method for the diagnosis of Tourette syndrome and associated disorders Grant 5,260,196 - Comings November 9, 1	1993-11-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.